Terminal osseous dysplasia with pigmentary defects

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Terminal osseous dysplasia with pigmentary defects | |
|---|---|
| File:X-linked dominant.svg | |
| Synonyms | TODPD |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Bone dysplasia, skin pigmentation abnormalities, digital anomalies |
| Complications | N/A |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Female carriers |
| Diagnosis | Clinical evaluation, genetic testing |
| Differential diagnosis | Other genetic disorders |
| Prevention | N/A |
| Treatment | Symptomatic treatment |
| Medication | N/A |
| Prognosis | Variable |
| Frequency | Rare |
| Deaths | Not directly life-threatening |
Terminal Osseous Dysplasia with Pigmentary Defects (TODPD) is a rare genetic disorder that affects the development of bones, skin, and teeth. This condition is characterized by a combination of skeletal abnormalities, pigmentary defects on the skin, and digital anomalies. The disorder is exclusively found in females, suggesting a possible X-linked dominant mode of inheritance.
Characteristics[edit]
TODPD is marked by several distinct features, primarily affecting the skeletal system. Individuals with this condition often exhibit digital anomalies, including shortened fingers (brachydactyly), malformed or absent nails, and occasionally, syndactyly, which is the fusion of two or more fingers. The osseous (bone) dysplasia primarily involves the terminal phalanges, the bones at the tips of the fingers and toes, leading to their underdevelopment or malformation. Pigmentary defects in TODPD manifest as linear or whorled nevoid hypermelanosis, which are streaks or swirls of increased pigmentation on the skin. These pigmentary changes are present from birth and do not follow a specific dermatomal distribution, differing from other pigmentary disorders. Dental anomalies are also common in TODPD, including delayed eruption of teeth, missing teeth (hypodontia), and in some cases, malformed teeth. These dental issues can lead to difficulties in chewing and oral hygiene maintenance.
Genetics[edit]
The exact genetic cause of Terminal Osseous Dysplasia with Pigmentary Defects is not fully understood, but it is believed to be related to mutations on the X chromosome, indicating an X-linked dominant inheritance pattern. This pattern explains the exclusive presence of the disorder in females, as males with a defective gene on their single X chromosome would not be viable. Research is ongoing to identify the specific gene(s) involved and to understand the mechanisms by which the mutations lead to the symptoms observed in TODPD.
Diagnosis[edit]
Diagnosis of TODPD is primarily based on clinical observation of the characteristic features, including the skeletal, dental, and skin abnormalities. Genetic testing may be helpful in confirming the diagnosis, especially in cases where the clinical presentation is atypical. Imaging studies, such as X-rays, can reveal the extent of bone dysplasia and digital anomalies.
Management[edit]
There is no cure for Terminal Osseous Dysplasia with Pigmentary Defects, and management focuses on addressing the symptoms and improving the quality of life for affected individuals. Orthopedic interventions may be necessary to correct skeletal deformities and improve function. Dental care, including orthodontic treatment, can help manage the dental anomalies. Dermatological consultation may be beneficial for managing the pigmentary skin changes, although these are generally cosmetic.
Prognosis[edit]
The prognosis for individuals with TODPD varies depending on the severity of the symptoms. While the condition does not typically affect life expectancy, the skeletal and dental anomalies can significantly impact quality of life and require ongoing management.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
